Literature DB >> 23386036

Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

Laura Maria Pradella1, Martin Lang, Ivana Kurelac, Elisa Mariani, Flora Guerra, Roberta Zuntini, Giovanni Tallini, Alan MacKay, Jorge S Reis-Filho, Marco Seri, Daniela Turchetti, Giuseppe Gasparre.   

Abstract

Birt-Hogg-Dubè (BHD) is an autosomal dominant syndrome characterised by skin fibrofolliculomas, lung cysts, spontaneous pneumothorax and renal cancer. The association of benign cutaneous lesions and increased cancer risk is also a feature of Cowden Syndrome (CS), an autosomal dominant disease caused by PTEN mutations. BHD and CS patients may develop oncocytomas, rare neoplasias that are phenotypically characterised by a prominent mitochondrial hyperplasia. We here describe the genetic analysis of a parotid and a thyroid oncocytoma, developed by a BHD and a CS patient, respectively. The BHD lesion was shown to maintain the wild-type allele of FLCN, while losing one PTEN allele. On the other hand, a double heterozygosity for the same two genes was found to be the only detectable tumorigenic hit in the CS oncocytoma. Both conditions occurred in a context of high chromosomal stability, as highlighted by comparative genomic hybridisation analysis. We conclude that, similarly to PTEN, FLCN may not always follow the classical Two Hits model of tumorigenesis and may hence belong to a class of non-canonical tumour suppressor genes. We hence introduce a role of PTEN/FLCN double heterozygosity in syndromic oncocytic tumorigenesis, suggesting this to be an alternative determinant to pathogenic mitochondrial DNA mutations, which are instead the genetic hallmark of sporadic oncocytic tumours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386036      PMCID: PMC3778364          DOI: 10.1038/ejhg.2013.8

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  20 in total

1.  Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.

Authors:  Masaya Baba; Seung-Beom Hong; Nirmala Sharma; Michelle B Warren; Michael L Nickerson; Akihiro Iwamatsu; Dominic Esposito; William K Gillette; Ralph F Hopkins; James L Hartley; Mutsuo Furihata; Shinya Oishi; Wei Zhen; Terrence R Burke; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-06       Impact factor: 11.205

2.  High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.

Authors:  Cathy D Vocke; Youfeng Yang; Christian P Pavlovich; Laura S Schmidt; Michael L Nickerson; Carlos A Torres-Cabala; Maria J Merino; McClellan M Walther; Berton Zbar; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

Review 3.  PGC-1alpha: a key regulator of energy metabolism.

Authors:  Huiyun Liang; Walter F Ward
Journal:  Adv Physiol Educ       Date:  2006-12       Impact factor: 2.288

4.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Authors:  Michael L Nickerson; Michelle B Warren; Jorge R Toro; Vera Matrosova; Gladys Glenn; Maria L Turner; Paul Duray; Maria Merino; Peter Choyke; Christian P Pavlovich; Nirmala Sharma; McClellan Walther; David Munroe; Rob Hill; Eamonn Maher; Cheryl Greenberg; Michael I Lerman; W Marston Linehan; Berton Zbar; Laura S Schmidt
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

5.  Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.

Authors:  Ivana Kurelac; Alan MacKay; Maryou B K Lambros; Erica Di Cesare; Giovanna Cenacchi; Claudio Ceccarelli; Isabella Morra; Antonio Melcarne; Luca Morandi; Francesco Maria Calabrese; Marcella Attimonelli; Giovanni Tallini; Jorge S Reis-Filho; Giuseppe Gasparre
Journal:  Hum Mol Genet       Date:  2012-10-09       Impact factor: 6.150

Review 6.  Oncocytic tumours.

Authors:  G Tallini
Journal:  Virchows Arch       Date:  1998-07       Impact factor: 4.064

7.  mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

Authors:  John T Cunningham; Joseph T Rodgers; Daniel H Arlow; Francisca Vazquez; Vamsi K Mootha; Pere Puigserver
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

8.  Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.

Authors:  Masaya Baba; Mutsuo Furihata; Seung-Beom Hong; Lino Tessarollo; Diana C Haines; Eileen Southon; Vishal Patel; Peter Igarashi; W Gregory Alvord; Robert Leighty; Masahiro Yao; Marcelino Bernardo; Lilia Ileva; Peter Choyke; Michelle B Warren; Berton Zbar; W Marston Linehan; Laura S Schmidt
Journal:  J Natl Cancer Inst       Date:  2008-01-08       Impact factor: 13.506

Review 9.  BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

Authors:  J R Toro; M-H Wei; G M Glenn; M Weinreich; O Toure; C Vocke; M Turner; P Choyke; M J Merino; P A Pinto; S M Steinberg; L S Schmidt; W M Linehan
Journal:  J Med Genet       Date:  2008-01-30       Impact factor: 6.318

10.  Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.

Authors:  Jindong Chen; Kunihiko Futami; David Petillo; Jun Peng; Pengfei Wang; Jared Knol; Yan Li; Sok-Kean Khoo; Dan Huang; Chao-Nan Qian; Ping Zhao; Karl Dykema; Karl Dykyma; Racheal Zhang; Brian Cao; Ximing J Yang; Kyle Furge; Bart O Williams; Bin Tean Teh
Journal:  PLoS One       Date:  2008-10-30       Impact factor: 3.240

View more
  10 in total

Review 1.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

2.  Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis.

Authors:  Leeanna El-Houjeiri; Marco Biondini; Mathieu Paquette; Helen Kuasne; Alain Pacis; Morag Park; Peter M Siegel; Arnim Pause
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

3.  Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

4.  Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.

Authors:  Martin Lang; Cathy D Vocke; Maria J Merino; Laura S Schmidt; W Marston Linehan
Journal:  Mod Pathol       Date:  2015-10-02       Impact factor: 7.842

5.  Parotid Oncocytoma as a Manifestation of Birt-Hogg-Dubé Syndrome.

Authors:  Kazuki Yoshida; Masao Miyagawa; Teruhito Kido; Kana Ide; Yoshifumi Sano; Yoshifumi Sugawara; Hiroyuki Takahata; Nobuya Monden; Mitsuko Furuya; Teruhito Mochizuki
Journal:  Case Rep Radiol       Date:  2018-06-03

6.  Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes.

Authors:  Mohammad Al-Shinnag; Helen Marfan; Rachel Susman; Jan Wakeling; Sonja Gustafson; Simon Wood; Andrew John Mallett
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

7.  Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome.

Authors:  Monica De Luise; Luisa Iommarini; Lorena Marchio; Greta Tedesco; Camelia Alexandra Coadă; Andrea Repaci; Daniela Turchetti; Maria Lucia Tardio; Nunzio Salfi; Uberto Pagotto; Ivana Kurelac; Anna Maria Porcelli; Giuseppe Gasparre
Journal:  Cells       Date:  2021-10-28       Impact factor: 6.600

8.  A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.

Authors:  Laura Maria Pradella; Cecilia Evangelisti; Claudia Ligorio; Claudio Ceccarelli; Iria Neri; Roberta Zuntini; Laura Benedetta Amato; Simona Ferrari; Alberto Maria Martelli; Giuseppe Gasparre; Daniela Turchetti
Journal:  BMC Cancer       Date:  2014-02-06       Impact factor: 4.430

9.  Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.

Authors:  Rebecca A Sager; Mark R Woodford; Oleg Shapiro; Mehdi Mollapour; Gennady Bratslavsky
Journal:  Oncotarget       Date:  2018-04-24

Review 10.  Inherited Thyroid Tumors With Oncocytic Change.

Authors:  Marcelo Correia; Ana Rita Lima; Rui Batista; Valdemar Máximo; Manuel Sobrinho-Simões
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.